Article info

Download PDFPDF
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling

Authors

  1. Correspondence to Professor Thomas Pap, Division of Molecular Medicine of Musculoskeletal Tissue, University Munster, Münster 48149, Germany; thomas.pap{at}uni-muenster.de
View Full Text

Citation

Godmann L, Bollmann M, Korb-Pap A, et al
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling

Publication history

  • Received December 19, 2019
  • Revised February 3, 2020
  • Accepted February 5, 2020
  • First published February 24, 2020.
Online issue publication 
March 19, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.